These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37274933)

  • 1. Poly (β-amino Ester) Nanoparticles Modified with a Rabies Virus-derived peptide for the Delivery of
    Rodgers TM; Muzzio N; Valero A; Ahmad I; Lüdtke TU; Moya SE; Romero G
    ACS Appl Nano Mater; 2023 Apr; 6(7):6299-6311. PubMed ID: 37274933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles.
    Liu Y; Huang R; Han L; Ke W; Shao K; Ye L; Lou J; Jiang C
    Biomaterials; 2009 Sep; 30(25):4195-202. PubMed ID: 19467700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer's Disease.
    Pinheiro RGR; Granja A; Loureiro JA; Pereira MC; Pinheiro M; Neves AR; Reis S
    Pharm Res; 2020 Jul; 37(7):139. PubMed ID: 32661727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells.
    Park NI; Guilhamon P; Desai K; McAdam RF; Langille E; O'Connor M; Lan X; Whetstone H; Coutinho FJ; Vanner RJ; Ling E; Prinos P; Lee L; Selvadurai H; Atwal G; Kushida M; Clarke ID; Voisin V; Cusimano MD; Bernstein M; Das S; Bader G; Arrowsmith CH; Angers S; Huang X; Lupien M; Dirks PB
    Cell Stem Cell; 2017 Aug; 21(2):209-224.e7. PubMed ID: 28712938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy.
    Hua H; Zhang X; Mu H; Meng Q; Jiang Y; Wang Y; Lu X; Wang A; Liu S; Zhang Y; Wan Z; Sun K
    Int J Pharm; 2018 May; 543(1-2):179-189. PubMed ID: 29555442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
    Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
    Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-targeted CRISPR/Cas9 nanomedicine for effective glioblastoma therapy.
    Ruan W; Jiao M; Xu S; Ismail M; Xie X; An Y; Guo H; Qian R; Shi B; Zheng M
    J Control Release; 2022 Nov; 351():739-751. PubMed ID: 36174804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles.
    Chen W; Zhan C; Gu B; Meng Q; Wang H; Lu W; Hou H
    J Drug Target; 2011 Apr; 19(3):228-34. PubMed ID: 20540685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic nanocarriers loaded with temozolomide by cloaking brain-targeting peptides for targeting drug delivery system to promote anticancer effects in glioblastoma cells.
    Chen H; Wang Y; Wang H; Zhang K; Liu Y; Li Q; Li C; Wen Z; Chen Z
    Heliyon; 2024 Apr; 10(7):e28256. PubMed ID: 38596030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-targeted delivery of PEGylated nano-bacitracin A against Penicillin-sensitive and -resistant Pneumococcal meningitis: formulated with RVG
    Hong W; Zhang Z; Liu L; Zhao Y; Zhang D; Liu M
    Drug Deliv; 2018 Nov; 25(1):1886-1897. PubMed ID: 30404541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiopep-2-Functionalized Lipid Cubosomes for Blood-Brain Barrier Crossing and Glioblastoma Treatment.
    Cai X; Refaat A; Gan PY; Fan B; Yu H; Thang SH; Drummond CJ; Voelcker NH; Tran N; Zhai J
    ACS Appl Mater Interfaces; 2024 Mar; 16(10):12161-12174. PubMed ID: 38416873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ethylene glycol)-Poly(beta-amino ester)-Based Nanoparticles for Suicide Gene Therapy Enhance Brain Penetration and Extend Survival in a Preclinical Human Glioblastoma Orthotopic Xenograft Model.
    Kim J; Mondal SK; Tzeng SY; Rui Y; Al-Kharboosh R; Kozielski KK; Bhargav AG; Garcia CA; Quiñones-Hinojosa A; Green JJ
    ACS Biomater Sci Eng; 2020 May; 6(5):2943-2955. PubMed ID: 33463272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex.
    Xin X; Liu W; Zhang ZA; Han Y; Qi LL; Zhang YY; Zhang XT; Duan HX; Chen LQ; Jin MJ; Wang QM; Gao ZG; Huang W
    Int J Nanomedicine; 2021; 16():5755-5776. PubMed ID: 34471351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Chen YC
    Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient antiglioblastoma therapy in mice through doxorubicin-loaded nanomicelles modified using a novel brain-targeted RVG-15 peptide.
    Han M; Xing H; Chen L; Cui M; Zhang Y; Qi L; Jin M; Yang Y; Gao C; Gao Z; Xing X; Huang W
    J Drug Target; 2021 Nov; 29(9):1016-1028. PubMed ID: 33825602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A brain targeting functionalized liposomes of the dopamine derivative N-3,4-bis(pivaloyloxy)-dopamine for treatment of Parkinson's disease.
    Qu M; Lin Q; He S; Wang L; Fu Y; Zhang Z; Zhang L
    J Control Release; 2018 May; 277():173-182. PubMed ID: 29588159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of curcumin-loaded zein nanoparticles for transport across the blood-brain barrier and inhibition of glioblastoma cell growth.
    Zhang H; van Os WL; Tian X; Zu G; Ribovski L; Bron R; Bussmann J; Kros A; Liu Y; Zuhorn IS
    Biomater Sci; 2021 Oct; 9(21):7092-7103. PubMed ID: 33538729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Small Molecule Delivery to the Brain and Spinal Cord via Intranasal Administration of Rabies Virus Glycoprotein (RVG29)-Modified PLGA Nanoparticles.
    Chung EP; Cotter JD; Prakapenka AV; Cook RL; DiPerna DM; Sirianni RW
    Pharmaceutics; 2020 Jan; 12(2):. PubMed ID: 31991664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma.
    Tsai YC; Vijayaraghavan P; Chiang WH; Chen HH; Liu TI; Shen MY; Omoto A; Kamimura M; Soga K; Chiu HC
    Theranostics; 2018; 8(5):1435-1448. PubMed ID: 29507632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
    Gu J; Al-Bayati K; Ho EA
    Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.